Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Netflix
NFLX
US Stock MarketDetailed Quotes
ACRS Aclaris Therapeutics
- 1.600
- +0.030+1.91%
Close Mar 21 16:00 ET
- 1.600
- 0.0000.00%
Post 20:01 ET
173.04MMarket Cap-0.94P/E (TTM)
1.620High1.550Low2.62MVolume1.580Open1.570Pre Close4.18MTurnover3.94%Turnover RatioLossP/E (Static)108.15MShares5.17052wk High1.11P/B106.09MFloat Cap0.95252wk Low--Dividend TTM66.30MShs Float33.880Historical High--Div YieldTTM4.46%Amplitude0.590Historical Low1.597Avg Price1Lot Size
Aclaris Therapeutics News
Aclaris Therapeutics | EFFECT: Others
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Balthaser Kevin
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Monahan Joseph
Aclaris Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aclaris Therapeutics | 10-K: FY2024 Annual Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | SCHEDULE 13G/A: Others
Aclaris Therapeutics | SCHEDULE 13G: Others
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Monahan Joseph
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Davis Hugh M.
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Balthaser Kevin
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Loerop James
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Monahan Joseph
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Loerop James
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Balthaser Kevin
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | EFFECT: Others
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.